Women aged 18-50 years with a viable singleton or twin intrauterine pregnancy between 8 0/7 and 41 6/7 weeks gestation based on the best obstetric estimate by ACOG criteria
Diagnosis of pre-gestational or gestational diabetes mellitus A2, admitted to the hospital for labor or other antepartum admissions (besides DKA or glucoregulation)
Able to understand the study, and having understood, provide written informed consent in English
Infants who survive to hospital discharge who are born to women enrolled in the study
You may not be if
Participation in another trial that may influence the primary outcome, without prior approval
Higher order pregnancy
History of severe skin allergy to adhesive products or CGM
DKA, admission for glucoregulation
COVID-19 PUI or confirmed positive
Clareo Health | Continuous Glucose Monitoring for Personal Protective Equipment Evaluation
